Crystal engineering of the composition of pharmaceutical phases
The carboxylic acid-pyridine supramolecular heterosynthon can be exploited to predictably generate binary crystalline phases involving rac-ibuprofen, rac-flurbiprofen or aspirin.
Gespeichert in:
| Veröffentlicht in: | Chemical communications (Cambridge, England) England), 2003-01 (2), p.186-187 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 187 |
|---|---|
| container_issue | 2 |
| container_start_page | 186 |
| container_title | Chemical communications (Cambridge, England) |
| container_volume | |
| creator | Walsh, R D Bailey Bradner, M W Fleischman, a S Morales, L A Moulton, a B Rodríguez-Hornedo, N Zaworotko, M J |
| description | The carboxylic acid-pyridine supramolecular heterosynthon can be exploited to predictably generate binary crystalline phases involving rac-ibuprofen, rac-flurbiprofen or aspirin. |
| doi_str_mv | 10.1039/b208574g |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73038091</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73038091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c299t-57db3d1e465465ef18361293aa86a7b1c7db848bd6314f5f8c129a69e2a4661f3</originalsourceid><addsrcrecordid>eNpFkMtKxDAUhoMozjgKPoF0JW6qSXNpshIZvMGAGwV3JU1PZiJtU5N2MW8_GWbEw4Fz-86_-BG6JvieYKoe6gJLXrL1CZoTKljOmfw-3fdc5SVlfIYuYvzBKQiX52hGCi45lXSOHpdhG0fdZtCvXQ8QXL_OvM3GDWTGd4OPbnS-36-GjQ6dNjCNzqSHNEaIl-jM6jbC1bEu0NfL8-fyLV99vL4vn1a5KZQac142NW0IMMFTgiWSClIoqrUUuqyJSXfJZN0ISpjlVpp01UJBoZkQxNIFuj3oDsH_ThDHqnPRQNvqHvwUq5JiKrEiCbw7gCb4GAPYagiu02FbEVztzar-zErozVFzqjto_sGjO3QHte1kCQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73038091</pqid></control><display><type>article</type><title>Crystal engineering of the composition of pharmaceutical phases</title><source>Royal Society of Chemistry Journals Archive (1841-2007)</source><source>Royal Society Of Chemistry Journals 2008-</source><source>Alma/SFX Local Collection</source><creator>Walsh, R D Bailey ; Bradner, M W ; Fleischman, a S ; Morales, L A ; Moulton, a B ; Rodríguez-Hornedo, N ; Zaworotko, M J</creator><creatorcontrib>Walsh, R D Bailey ; Bradner, M W ; Fleischman, a S ; Morales, L A ; Moulton, a B ; Rodríguez-Hornedo, N ; Zaworotko, M J</creatorcontrib><description>The carboxylic acid-pyridine supramolecular heterosynthon can be exploited to predictably generate binary crystalline phases involving rac-ibuprofen, rac-flurbiprofen or aspirin.</description><identifier>ISSN: 1359-7345</identifier><identifier>EISSN: 1364-548X</identifier><identifier>DOI: 10.1039/b208574g</identifier><identifier>PMID: 12585383</identifier><language>eng</language><publisher>England</publisher><ispartof>Chemical communications (Cambridge, England), 2003-01 (2), p.186-187</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c299t-57db3d1e465465ef18361293aa86a7b1c7db848bd6314f5f8c129a69e2a4661f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,2820,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12585383$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Walsh, R D Bailey</creatorcontrib><creatorcontrib>Bradner, M W</creatorcontrib><creatorcontrib>Fleischman, a S</creatorcontrib><creatorcontrib>Morales, L A</creatorcontrib><creatorcontrib>Moulton, a B</creatorcontrib><creatorcontrib>Rodríguez-Hornedo, N</creatorcontrib><creatorcontrib>Zaworotko, M J</creatorcontrib><title>Crystal engineering of the composition of pharmaceutical phases</title><title>Chemical communications (Cambridge, England)</title><addtitle>Chem Commun (Camb)</addtitle><description>The carboxylic acid-pyridine supramolecular heterosynthon can be exploited to predictably generate binary crystalline phases involving rac-ibuprofen, rac-flurbiprofen or aspirin.</description><issn>1359-7345</issn><issn>1364-548X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNpFkMtKxDAUhoMozjgKPoF0JW6qSXNpshIZvMGAGwV3JU1PZiJtU5N2MW8_GWbEw4Fz-86_-BG6JvieYKoe6gJLXrL1CZoTKljOmfw-3fdc5SVlfIYuYvzBKQiX52hGCi45lXSOHpdhG0fdZtCvXQ8QXL_OvM3GDWTGd4OPbnS-36-GjQ6dNjCNzqSHNEaIl-jM6jbC1bEu0NfL8-fyLV99vL4vn1a5KZQac142NW0IMMFTgiWSClIoqrUUuqyJSXfJZN0ISpjlVpp01UJBoZkQxNIFuj3oDsH_ThDHqnPRQNvqHvwUq5JiKrEiCbw7gCb4GAPYagiu02FbEVztzar-zErozVFzqjto_sGjO3QHte1kCQ</recordid><startdate>20030121</startdate><enddate>20030121</enddate><creator>Walsh, R D Bailey</creator><creator>Bradner, M W</creator><creator>Fleischman, a S</creator><creator>Morales, L A</creator><creator>Moulton, a B</creator><creator>Rodríguez-Hornedo, N</creator><creator>Zaworotko, M J</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030121</creationdate><title>Crystal engineering of the composition of pharmaceutical phases</title><author>Walsh, R D Bailey ; Bradner, M W ; Fleischman, a S ; Morales, L A ; Moulton, a B ; Rodríguez-Hornedo, N ; Zaworotko, M J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c299t-57db3d1e465465ef18361293aa86a7b1c7db848bd6314f5f8c129a69e2a4661f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Walsh, R D Bailey</creatorcontrib><creatorcontrib>Bradner, M W</creatorcontrib><creatorcontrib>Fleischman, a S</creatorcontrib><creatorcontrib>Morales, L A</creatorcontrib><creatorcontrib>Moulton, a B</creatorcontrib><creatorcontrib>Rodríguez-Hornedo, N</creatorcontrib><creatorcontrib>Zaworotko, M J</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Chemical communications (Cambridge, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Walsh, R D Bailey</au><au>Bradner, M W</au><au>Fleischman, a S</au><au>Morales, L A</au><au>Moulton, a B</au><au>Rodríguez-Hornedo, N</au><au>Zaworotko, M J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Crystal engineering of the composition of pharmaceutical phases</atitle><jtitle>Chemical communications (Cambridge, England)</jtitle><addtitle>Chem Commun (Camb)</addtitle><date>2003-01-21</date><risdate>2003</risdate><issue>2</issue><spage>186</spage><epage>187</epage><pages>186-187</pages><issn>1359-7345</issn><eissn>1364-548X</eissn><abstract>The carboxylic acid-pyridine supramolecular heterosynthon can be exploited to predictably generate binary crystalline phases involving rac-ibuprofen, rac-flurbiprofen or aspirin.</abstract><cop>England</cop><pmid>12585383</pmid><doi>10.1039/b208574g</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1359-7345 |
| ispartof | Chemical communications (Cambridge, England), 2003-01 (2), p.186-187 |
| issn | 1359-7345 1364-548X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73038091 |
| source | Royal Society of Chemistry Journals Archive (1841-2007); Royal Society Of Chemistry Journals 2008-; Alma/SFX Local Collection |
| title | Crystal engineering of the composition of pharmaceutical phases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T03%3A02%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Crystal%20engineering%20of%20the%20composition%20of%20pharmaceutical%20phases&rft.jtitle=Chemical%20communications%20(Cambridge,%20England)&rft.au=Walsh,%20R%20D%20Bailey&rft.date=2003-01-21&rft.issue=2&rft.spage=186&rft.epage=187&rft.pages=186-187&rft.issn=1359-7345&rft.eissn=1364-548X&rft_id=info:doi/10.1039/b208574g&rft_dat=%3Cproquest_cross%3E73038091%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73038091&rft_id=info:pmid/12585383&rfr_iscdi=true |